01697nam a2200193Ia 4500003000400000005001700004008004100021050003100062100001800093245007500111264003400186300002900220500001900249505111500268650004001383650003001423650002801453650002201481OSt20260718102836.0230508s2022 xx 000 0 und d aAllied HD 9665.5bK48 20221 aMoorman, Mike10aKey account management excellence in pharma & medtech /cMike Moorman. aLondon : bRoutledge, c2022. axxv, 216 pages ;c24 cm. aIncludes index0 ach. 1. Kam is a business strategy, not a role — ch. 2. The rise of the organized customer and kam in healthcare — ch. 3. Where to play: key account segmentation and selection — ch. 4. Value strategy: evolving from basic offerings to advanced solutions — ch. 5. Kam organization design: form follows function — ch. 6. Executive alignment and engagement: its make or break for life sciences kam program — ch. 7. Kam program office: marshalling the internal support required for results — ch. 8. The long and short of kam matrics — ch. 9. Customer engagement process: the secret to agile execution — ch. 10. Bringing value to account planning and management — ch. 11. Context is king: laying the foundation for a comprehensive kam talent strategy — ch. 12. The unique learning journey required for kam — ch. 13. Key account manager incentive compensation: aligning to strategic objectives — ch. 14. Why technology is critical for breathing life into kam — ch. 15. Kam in the United States versus Europe: are we headed to the same place? — ch. 16. The future of kam in life science.  0aPharmaceutical industryxManagement 0aMedical supplies industry 0aMarketingxKey accounts 0aCustomer services